These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26777395)

  • 1. Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.
    Irimia A; Sarkar A; Stanfield RL; Wilson IA
    Immunity; 2016 Jan; 44(1):21-31. PubMed ID: 26777395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
    Guenaga J; Wyatt RT
    PLoS Pathog; 2012; 8(7):e1002806. PubMed ID: 22829767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
    Virology; 2017 May; 505():113-126. PubMed ID: 28237764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
    Cardoso RM; Zwick MB; Stanfield RL; Kunert R; Binley JM; Katinger H; Burton DR; Wilson IA
    Immunity; 2005 Feb; 22(2):163-73. PubMed ID: 15723805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes.
    Franquelim HG; Chiantia S; Veiga AS; Santos NC; Schwille P; Castanho MA
    AIDS; 2011 Feb; 25(4):419-28. PubMed ID: 21245727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Membrane Interactions Boost the Engagement by an Anti-HIV-1 Broadly Neutralizing Antibody.
    Rujas E; Caaveiro JM; Insausti S; García-Porras M; Tsumoto K; Nieva JL
    J Biol Chem; 2017 Mar; 292(13):5571-5583. PubMed ID: 28213514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.
    Xu H; Song L; Kim M; Holmes MA; Kraft Z; Sellhorn G; Reinherz EL; Stamatatos L; Strong RK
    J Virol; 2010 Jan; 84(2):1076-88. PubMed ID: 19906921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions.
    Dennison SM; Stewart SM; Stempel KC; Liao HX; Haynes BF; Alam SM
    J Virol; 2009 Oct; 83(19):10211-23. PubMed ID: 19640992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane.
    Rujas E; Insausti S; García-Porras M; Sánchez-Eugenia R; Tsumoto K; Nieva JL; Caaveiro JM
    J Mol Biol; 2017 Apr; 429(8):1213-1226. PubMed ID: 28300601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
    Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
    J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
    Dieltjens T; Heyndrickx L; Willems B; Gray E; Van Nieuwenhove L; Grupping K; Vanham G; Janssens W
    Retrovirology; 2009 Dec; 6():113. PubMed ID: 20003438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
    J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.
    Rujas E; Leaman DP; Insausti S; Ortigosa-Pascual L; Zhang L; Zwick MB; Nieva JL
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions.
    Scherer EM; Leaman DP; Zwick MB; McMichael AJ; Burton DR
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1529-34. PubMed ID: 20080706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
    AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10.
    Finton KA; Larimore K; Larman HB; Friend D; Correnti C; Rupert PB; Elledge SJ; Greenberg PD; Strong RK
    PLoS Pathog; 2013; 9(9):e1003639. PubMed ID: 24086134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.
    Venditto VJ; Watson DS; Motion M; Montefiori D; Szoka FC
    Clin Vaccine Immunol; 2013 Jan; 20(1):39-45. PubMed ID: 23114698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity.
    Donius LR; Cheng Y; Choi J; Sun ZY; Hanson M; Zhang M; Gierahn TM; Marquez S; Uduman M; Kleinstein SH; Irvine D; Love JC; Reinherz EL; Kim M
    J Virol; 2016 Oct; 90(19):8875-90. PubMed ID: 27466419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.
    Irimia A; Serra AM; Sarkar A; Jacak R; Kalyuzhniy O; Sok D; Saye-Francisco KL; Schiffner T; Tingle R; Kubitz M; Adachi Y; Stanfield RL; Deller MC; Burton DR; Schief WR; Wilson IA
    PLoS Pathog; 2017 Feb; 13(2):e1006212. PubMed ID: 28225819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.